News and Trends 1 Jun 2022
GSK to acquire clinical-stage biopharmaceutical company Affinivax
GSK plc is set to acquire Affinivax, Inc., a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1B upfront payment and up to $1.2B in potential development milestones. …